CLINICAL_TRIALS
trial_result
· 2015-03-11
Clinical Trial Update: Trial of CF101 to Treat Patients With Dry Eye Disease [Phase 3]
Summary
Phase 3 trial of CF101 for dry eye disease (keratoconjunctivitis sicca) completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Can-Fite BioPharma | Conditions: Keratoconjunctivitis Sicca | Phase 3 | Status: COMPLETED | Results posted: 2015-03-11